Researchers at the Jacobs School of Medicine and Biomedical Sciences have developed a new inhalable form of tuberculosis (TB) treatment that could significantly reduce the burden of current therapy.

A more accurate understanding of this pathogenic mechanism could provide a target against the bacterium that caused 1.6 million deaths in 2021, along with 10 million new cases of tuberculosis every ...

Forbes contributors publish independent expert analyses and insights. I write about health and U.K. health policy. Although it's often thought of as a disease of the past, tuberculosis is still found ...